Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taroh Satoh

Showing results (41-50 of 277) with videos related to

Pageof 28
Sort By:
Cancer Research|March 3, 2007
Differential constitutive activation of the epidermal growth factor receptor in non-small cell lung cancer cells bearing EGFR gene mutation and amplificationTakafumi Okabe, Isamu Okamoto, Kenji Tamura, et al.
Heliyon|December 25, 2018
Drug discovery of anticancer drugs targeting methylenetetrahydrofolate dehydrogenase 2Ayumu Asai, Jun Koseki, Masamitsu Konno, et al.
Cancers|April 3, 2021
Clinical Utility of Next-Generation Sequencing-Based Panel Testing under the Universal Health-Care System in Japan: A Retrospective Analysis at a Single University HospitalChiaki Inagaki, Daichi Maeda, Kazue Hatake, et al.
Journal of Gastroenterology|August 23, 2011
Cancer stem cell theory in gastrointestinal malignancies: recent progress and upcoming challengesDyah Laksmi Dewi, Hideshi Ishii, Yoshihiro Kano, et al.
Annals of Surgical Oncology|February 11, 2025
ASO Visual Abstract: Phase I/II Study of Neoadjuvant Chemoradiotherapy Consisting of S-1 and Cisplatin for Patients with Clinically Resectable Type 4 or Large Type 3 Gastric Cancer (OGSG1205)Masayuki Shinkai, Motohiro Imano, Masaki Yokokawa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 4, 2013
Innovative cell-modifying technology targeting cancer stem cellHideshi Ishii, Masamitsu Konno, Yoshinori Kagawa, et al.
Clinical Journal of Gastroenterology|February 10, 2021
An oncologic emergency case of massive dedifferentiated liposarcoma of the small bowel mesenteryRyota Mori, Takayuki Ogino, Shiki Fujino, et al.
BMC Cancer|September 20, 2019
Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: a prospective, multicenter, open-label, single-arm phase II studyTsunekazu Mizushima, Masataka Ikeda, Takeshi Kato, et al.
Anticancer Research|March 10, 2015
Circulating hepatocyte growth factor is correlated with resistance to cetuximab in metastatic colorectal cancerKimio Yonesaka, Taroh Satoh, Shinya Ueda, et al.
Japanese Journal of Clinical Oncology|July 16, 2013
A phase II trial of trastuzumab combined with irinotecan in patients with advanced HER2-positive chemo-refractory gastric cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group OGSG1203 (HERBIS-5)Daisuke Sakai, Taroh Satoh, Yukinori Kurokawa, et al.
Pageof 28

Showing results (41-50 of 277) with videos related to

Sort By:
Pageof 28
Cancer Research|March 3, 2007
Differential constitutive activation of the epidermal growth factor receptor in non-small cell lung cancer cells bearing EGFR gene mutation and amplificationTakafumi Okabe, Isamu Okamoto, Kenji Tamura, et al.
Heliyon|December 25, 2018
Drug discovery of anticancer drugs targeting methylenetetrahydrofolate dehydrogenase 2Ayumu Asai, Jun Koseki, Masamitsu Konno, et al.
Cancers|April 3, 2021
Clinical Utility of Next-Generation Sequencing-Based Panel Testing under the Universal Health-Care System in Japan: A Retrospective Analysis at a Single University HospitalChiaki Inagaki, Daichi Maeda, Kazue Hatake, et al.
Journal of Gastroenterology|August 23, 2011
Cancer stem cell theory in gastrointestinal malignancies: recent progress and upcoming challengesDyah Laksmi Dewi, Hideshi Ishii, Yoshihiro Kano, et al.
Annals of Surgical Oncology|February 11, 2025
ASO Visual Abstract: Phase I/II Study of Neoadjuvant Chemoradiotherapy Consisting of S-1 and Cisplatin for Patients with Clinically Resectable Type 4 or Large Type 3 Gastric Cancer (OGSG1205)Masayuki Shinkai, Motohiro Imano, Masaki Yokokawa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 4, 2013
Innovative cell-modifying technology targeting cancer stem cellHideshi Ishii, Masamitsu Konno, Yoshinori Kagawa, et al.
Clinical Journal of Gastroenterology|February 10, 2021
An oncologic emergency case of massive dedifferentiated liposarcoma of the small bowel mesenteryRyota Mori, Takayuki Ogino, Shiki Fujino, et al.
BMC Cancer|September 20, 2019
Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: a prospective, multicenter, open-label, single-arm phase II studyTsunekazu Mizushima, Masataka Ikeda, Takeshi Kato, et al.
Anticancer Research|March 10, 2015
Circulating hepatocyte growth factor is correlated with resistance to cetuximab in metastatic colorectal cancerKimio Yonesaka, Taroh Satoh, Shinya Ueda, et al.
Japanese Journal of Clinical Oncology|July 16, 2013
A phase II trial of trastuzumab combined with irinotecan in patients with advanced HER2-positive chemo-refractory gastric cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group OGSG1203 (HERBIS-5)Daisuke Sakai, Taroh Satoh, Yukinori Kurokawa, et al.
Pageof 28